Obagi Medical Products, Inc. (OMPI) Misses Q1 EPS by 5c
Get Alerts OMPI Hot Sheet
Price: $23.98 --0%
Financial Fact:
Income from operations: 5.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income from operations: 5.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q1 EPS of $0.16, $0.05 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $28.14 million.
Obagi Medical Products, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Obagi Medical Products, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share